UBS raises Paychex price target to $115, maintains Neutral
UBS analyst Kevin Mcveigh maintained a Neutral rating on Paychex (NASDAQ: PAYX) and raised the price target from $105 to $115, indicating an updated valuation outlook.

*this image is generated using AI for illustrative purposes only.
UBS analyst Kevin Mcveigh has maintained a Neutral rating on Paychex (NASDAQ: PAYX) while adjusting the stock's valuation expectations. The firm raised its price target for the company to $115, up from the previous target of $105.
The revision reflects an updated outlook on the stock's potential price movement, though the overall Neutral stance suggests the analyst expects the shares to perform in line with the broader market. The new price target of $115 indicates a specific level where UBS believes the stock could fairly trade.
Paychex provides payroll, human resource, and benefits outsourcing solutions for small to medium-sized businesses. The company's performance is often closely tied to employment trends and small business health.
What specific factors could drive Paychex's stock to outperform the broader market despite the Neutral rating?
How might changing employment trends impact Paychex's revenue growth in the coming quarters?
Could Paychex see increased demand for its services if small businesses face economic uncertainty?

































